Treatment of Opioid Use Disorder Course: OB/GYN Focus
- Non-Member - $199
- Regular Member - $149
- Retired - $149
- Early Career Physician - $149
- Resident - $99
- Student - $99
- Associate - $99
- ASAM Staff - Free!
- International Member - $149
- Emeritus Member - $149
- Provisional Member - $149
- Fellow Member - $149
- Honorary Member - $149
- CRT Member - $149
This 8-hour, online course provides the education that is essential for providers to identify, assess, diagnose, and manage pregnant and postpartum patients with opioid use disorder (OUD). The curriculum for this course has been specifically designed for women's healthcare providers. It covers all medications and treatments for OUD and provides the education needed to prescribe buprenorphine.
Please Note: That recent legislation has removed the waiver requirement to prescribe buprenorphine. Some of the course content and descriptions refer to the waiver and we appreciate your patience as we work to update this content. To learn more about federal buprenorphine prescribing regulations, check out Policies Governing Buprenorphine for Opioid Use Disorder.
The target audience for this introductory activity includes Physicians, Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists, and Certified Nurse Midwives seeking to treat opioid use disorder and prescribe buprenorphine in an office-based setting. All members of the healthcare team are encouraged to take the course.
This activity addresses the following ACGME Competencies: Patient Care, Medical Knowledge
Upon completion, participants should be able to:
- Identify, assess and diagnose pregnant and postpartum patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities.
- Explain the clinical pharmacology, safety, and efficacy of medications for opioid use disorder (MOUD) in pregnant people as well as in antepartum, postpartum, and breastfeeding periods.
- Develop an individualized, patient-centered treatment plan, including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options.
- Implement best practices for medication induction in pregnant and postpartum patients for the treatment of opioid use disorder.
- Discuss successful non-pharmacological ways to treat neonatal opioid withdrawal syndrome (NOWS).
- Monitor progress and modify treatment plans based on patient needs and progress toward treatment goals.
- Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with opioid use disorder and the use of medications to treat opioid use disorder.
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets the DEA requirement for 8 hours of education on substance use disorder(s).
|ASAM Learner Type||Rate|
*Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to Education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 09/20/2024
This content has been made available in part by a small unrestricted educational grant from Indivior, Inc. No input or influence from Indivior, was included in the development of the educational content. As an ACCME Provider, ASAM follows the ACCME Standards for Integrity and Independence for Accredited Continuing Education stating that owners and employees of ineligible companies are excluded from participating as planners or faculty, and must not be allowed to influence or control any aspect of the planning, delivery, or evaluation of accredited continuing education.
- Click on the Contents tab to begin this activity.
- Click Complete Post Test after each module to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 70% of questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Larry Leeman, MD, MPH is a Professor of Family and Community Medicine, Obstetrics and Gynecology at the University of New Mexico School of Medicine. He is a family physician with a focus on the care of pregnant women and newborns including perinatal substance abuse issues. He is Medical Director of the Milagro Program that provides prenatal care and maternity care services to women with substance use disorder. He directs the Family Medicine Maternal and Child Health service and fellowship and co-medical director of the UNM Hospital Mother-Baby Unit and Intermediate Care Nursery units. Dr. Leeman is Board Certified in Addiction Medicine by the ABPM. Dr. Leeman received his medical degree from University of California, San Francisco and MPH from University of California Berkeley in 1988. He completed residency training in Family Medicine at UNM and obstetrics fellowship at the University of Rochester and is the Medical Editor of the AAFP Advanced Life Support in Obstetrics patient safety program. His areas of research include perinatal substance abuse, neonatal opioid withdrawal syndrome and rural maternity care.
No Relevant Financial Disclosures
Yngvild K. Olsen
MD, MPH, DFASAM
Yngvild K. Olsen, MD, MPH, DFASAM graduated from Harvard Medical School in 1997, from the residency training program in internal medicine at Boston Medical Center in 2000, and from the Fellowship in General Internal Medicine at the Johns Hopkins School of Medicine in 2001. Dr. Olsen also serves as the Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services in Baltimore City. Dr. Olsen currently serves as Vice President of the American Society of Addiction Medicine and is a member of the Public Policy Committee. She is the Immediate Past President of the Maryland Society of Addiction Medicine, Immediate Past President of the Maryland Association for the Treatment of Opioid Dependence, and a Board member of the National Council on Alcoholism and Drug Dependence-MD (NCADD-MD).
No relevant financial disclosures
MD, MPH, DFASAM
Vania Rudolf, MD, MPH, DFASAM is a family and addiction medicine physician who is providing care to pregnant and parenting women with substance use disorder. She has a background in family medicine with OB and has completed Fellowships in Integrative Medicine, Addiction Medicine and High Risk Obstetrics at Swedish Medical Center. She has earned public health training at the UW. Dr. Rudolf continues to be a compassionate advocate for improving kind non-judgmental services and removing barriers to care. Providing compassionate trauma-responsive care to vulnerable women, babies and families is the primary focus of her practice in addition to clinical research related to clinical outcomes for substance use disorder, transition to MAT and prescribing policies to optimize safe and adequate postpartum analgesia management. She is the Medical Director for Addiction Recovery Services at Swedish Medical Center, an assistant professor at University of Washington, Seattle, WA and the Chair for the National Womens' Addiction Group related to the American Society of Addiction Medicine. She serves on the maternal mortality review board for the state of Washington and has many years as a practicing clinician.
No Relevant Financial Disclosures
Edwin A. Salsitz
Dr. Edwin Salsitz has been an attending physician at Mt. Sinai Beth Israel, Division of Chemical Dependency, in New York City since 1983, and is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM) and the Board of Internal Medicine and Pulmonary Disease.
No relevant financial disclosures
MD, MPH, FACOG, FASAM
Mishka Terplan, MD, MPH, FACOG, FASAM is board certified in both obstetrics and gynecology and in addiction medicine. His clinical, research and advocacy interests lie along the intersection of reproductive and behavioral health. He attended medical school at the University of California, San Francisco, Residency at the University of Southern California, and completed a research fellowship at the University of North Carolina, Chapel Hill. He was previously a Professor in both Obstetrics and Gynecology and Psychiatry and the Associate Director of Addiction Medicine at Virginia Commonwealth University. He is currently the Associate Medical Director of Friends Research Institute and he is a clinician for the National Clinician Consultation Center Substance Use Warmline. He additionally serves as Deputy Chief Clinical Officer for the Department of Behavioral Health, Washington DC. He is the Addiction Medicine Consultant for DMAS (Department of Medicaid Services, VA) and a consultant for the National Center on Substance Abuse and Child Welfare. Dr. Terplan has active grant funding and has published over 70 peer-reviewed articles with recent emphasis on health disparities, stigma, and women’s access to treatment. He has spoken before the United States Congress and has participated in expert panels at CDC, SAMHSA, ONDCP and NIH primarily on issues related to gender and addiction.
No Relevant Financial Disclosures
Matt Tierney, APRN is a Nurse Practitioner and a Clinical Professor at the UCSF School of Nursing. He also serves as Clinical Director of Substance Use Treatment and Education for the Office of Population Health at UCSF Health. The focus of his career has been on improving essential addiction treatment delivery locally, regionally, and nationally. He is a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on Psychiatric-Mental Health and Substance Use. Matt is also President-Elect of the American Psychiatric Nurses Association and represents APNA as a sponsoring member of the National Academies of Science Engineering and Medicine's Forum of Mental Health and Substance Use Disorders. He is an ASAM member who has been teaching waiver training courses since 2008. He has treated over 1,600 patients with buprenorphine and has worked in licensed Opiate Treatment programs providing all three FDA-approved medications for OUD treatment.
No relevant financial disclosures
MD, MS, FACOG, FASAM
Tricia Wright, MD MS is a Professor of Clinical Medicine in the Department of Obstetrics, Gynecology and Reproductive Health at the University of California, San Francisco. Previously she was at the University of Hawaii and founded the Path Clinic, a perinatal clinic specializing in the care of pregnant and parenting women with Substance Use Disorders. She is board certified in both Obstetrics and Gynecology and Addiction Medicine and a Fellow of the American College of Obstetrics and Gynecology and a Distinguished Fellow of the American Society of Addiction Medicine. She has published multiple papers on pregnancy and addiction as well as a textbook Opioid Use Disorders in Pregnancy published in 2018 by Cambridge University Press.Dr. Wright completed her undergraduate degree in Biological Sciences from Stanford University, her MD from the University of Michigan. She completed her residency in Obstetrics and Gynecology from the University of New Mexico and obtained a Master’s Degree in Clinical Research from the University of Hawai‘i.
Does Disclose - McKesson - Consultant
CME, CE, CEU and other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.
American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
Royal College of Physicians and Surgeons of Canada (RCPSC)
Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
|Access Date||Quiz Result||Score||Actions|